THE
In a dimly lit Indian warehouse, rows of plain unmarked sacks sit neatly on the floor, awaiting inspection.
Illustration — AI-generated
3004

India tightens drug licence rules

India has proposed rules requiring regulators to immediately suspend manufacturing licences for medicines that fail quality standards in government testing.

The licence would remain suspended until the manufacturer provides a root-cause analysis and corrective actions to the regulator’s satisfaction.

Source: TradingView

More on medicines

HS 3004